MODVQ · As filed with the SEC
ModivCare income statement, by fiscal year
The statement as ModivCare presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Operations · USD thousands, except per-share amounts
| USD thousands, except per-share amounts | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|
| Service revenue, net | 2,787,586 | 2,751,170 | 2,504,393 |
| Grant income (Note 2) | 0 | 5,037 | 7,351 |
| Operating expenses: | |||
| Service expense | 2,367,215 | 2,304,218 | 2,032,074 |
| General and administrative expense | 298,391 | 304,564 | 322,171 |
| Depreciation and amortization | 109,465 | 104,271 | 100,415 |
| Impairment of goodwill | 105,302 | 183,100 | 0 |
| Total operating expenses | 2,880,373 | 2,896,153 | 2,454,660 |
| Operating income (loss) | (92,787) | (139,946) | 57,084 |
| Interest expense, net | 94,053 | 69,120 | 61,961 |
| Loss on debt extinguishment | 11,797 | 0 | 0 |
| Loss before income taxes and equity method investment | (198,637) | (209,066) | (4,877) |
| Income tax benefit | 5,506 | 4,319 | 3,035 |
| Equity in net income (loss) of investee, net of tax | (8,147) | 287 | (29,964) |
| Net income (loss) | (201,278) | (204,460) | (31,806) |
| Loss per common share: | |||
| Basic (in dollars per share) | (14.14) | (14.43) | (2.26) |
| Diluted (in dollars per share) | (14.14) | (14.43) | (2.26) |
| Weighted-average number of common shares outstanding: | |||
| Basic (in shares) | 14,239,549 | 14,173,957 | 14,061,839 |
| Diluted (in shares) | 14,239,549 | 14,173,957 | 14,061,839 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.